Duchenne muscular dystrophy (DMD for short) is a genetic problem that is characterized by a gradual muscle deterioration and the development of weakness because of the differences to a protein called dystrophin that is needed to maintain muscle cells intact. Duchenne muscular dystrophy was first explained by the French neurologist Guillaume Benjamin Amand Duchenne back in1860. Duchenne muscular dystrophy is one kind of several conditions in a group called the dystrophinopathies which also includes Becker Muscular dystrophy. The beginning of DMD symptoms is frequently in early childhood. The condition mainly affects males, however females are affected on rare occasions. The occurrence of DMD is about 6 per 100,000 individuals.
The key characteristic of Duchenne muscular dystrophy is muscle weakness that may start off as early as ages 2 or 3. The weakness to begin with actually starts to impact the proximal muscle groups that are the muscles that are nearer to the core of the body. It is not until later on when the more distal limb muscles will be affected. Generally, the lower limb muscle groups will be affected before the upper limb muscle groups. The affected child commonly presents with having trouble leaping, running, as well as walking. Some of the other clinical features feature an growth of the calf muscles, a waddling type of walking, as well as an inward contour of the spinal column. Later on, as the heart and breathing muscle groups turn out to be damaged too, ultimately causing troubles there. The gradual weakness and back muscle weakness results in an impaired lung mobility, that may ultimately trigger a severe respiratory failure, and this can be fatal. Becker muscular dystrophy is a a lot like Duchenne muscular dystrophy, however the onset is generally during the teenage years and the condition natural history for it is slower and is much less predictable in comparison to the Duchenne muscular dystrophy.
In 1986 scientists identified a precise gene on the X chromosome which, when flawed (mutated), brings about Duchenne muscular dystrophy. The actual necessary protein associated with this gene was soon identified and termed dystrophin. It was the deficiency of the dystrophin protein in muscle cells causes them to end up being weak and readily damaged. Duchenne muscular dystrophy has an X-linked recessive inheritance pattern which is handed down through the mother, who is referred to as a carrier. The females who are carriers possess a typical dystrophin gene on one X chromosome and an irregular dystrophin gene on the other side X chromosome. The majority of carriers of DMD don’t themselves have symptoms of the condition.
At this time there is no remedy for Duchenne muscular dystrophy though the treatment can help prolong the time someone who has the disease usually stays mobile and help with heart and lung muscle strength. The therapy solutions include medications, physical rehabilitation as well as occupational therapy, and surgical along with other surgical procedures. Continuing checks of gait, swallowing, breathing and hand function are done by the treatment team in order that they will modify treatments since the disease advances. A short while ago boys that get DMD usually didn’t live much beyond their teen years. More recent progress in cardiac and respiratory system treatment has resulted in a life span improving and lots of young adults that have DMD can now show up at university, get married, and also have children. Life expectancy in to the thirties has become common.
- Yasmeh, Joseph (Author)
- English (Publication Language)
- Amazon Kindle Edition
- English (Publication Language)
- Hardcover Book
- Emery, Alan E. H. (Author)
I get commissions for purchases made through links on this website. As an Amazon Associate I earn from qualifying purchases.